Home › Calculator › LPCUF Dividend Calculator 2026
LPCUF DRIP Calculator & Dividend Yield 2026
3.00% YieldHealthcareLee's Pharmaceutical Holdings Limited · OTC
Price: $0.19 · Annual div: $0.0057/share · Frequency: annual · Payout ratio: 4% · Ex-div: 2026-09-29
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When LPCUF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
LPCUF Dividend History — Last 38 Payments
| Ex-Dividend Date | Payment Date | Amount / Share | TTM Yield | Stock Price |
|---|---|---|---|---|
| 2026-09-29Latest | 2026-10-16 | $0.0045 | 3.89% | $0.19 |
| 2026-05-29 | 2026-06-15 | $0.0029 | 4.68% | $0.19 |
| 2025-09-16 | 2025-10-03 | $0.0028 | 3.19% | $0.19 |
| 2025-05-30 | 2025-06-16 | $0.0032 | 3.07% | $0.19 |
| 2024-09-12 | 2024-10-03 | $0.0026 | 3,858.00% | $0.00 |
| 2024-05-28 | 2024-06-17 | $0.0013 | 2,315.00% | $0.00 |
| 2023-09-12 | 2023-10-04 | $0.0010 | 2,315.00% | $0.00 |
| 2023-05-25 | 2023-06-15 | $0.0013 | 6,558.00% | $0.00 |
| 2022-09-08 | 2022-09-27 | $0.0013 | 2.61% | $0.35 |
| 2022-05-26 | 2022-06-15 | $0.0040 | 3.38% | $0.35 |
| 2021-09-15 | 2021-10-06 | $0.0039 | 0.68% | $1.15 |
| 2021-05-31 | 2021-06-18 | $0.0040 | 0.65% | $1.15 |
| 2020-09-14 | 2020-09-30 | $0.0035 | — | — |
| 2020-05-27 | 2020-06-15 | $0.0049 | — | — |
| 2019-09-12 | 2019-09-30 | $0.0023 | — | — |
| 2019-05-24 | 2019-06-13 | $0.0107 | — | — |
| 2018-09-11 | 2018-09-27 | $0.0043 | — | — |
| 2018-05-21 | 2018-06-13 | $0.0089 | — | — |
| 2017-09-11 | 2017-09-27 | $0.0044 | — | — |
| 2017-05-23 | 2017-06-15 | $0.0101 | — | — |
| 2016-09-12 | 2016-09-28 | $0.0042 | — | — |
| 2016-05-20 | 2016-06-16 | $0.0095 | — | — |
| 2015-09-14 | 2015-10-15 | $0.0039 | — | — |
| 2015-05-15 | 2015-06-11 | $0.0085 | — | — |
| 2014-09-15 | 2014-10-16 | $0.0035 | — | — |
| 2014-05-16 | 2014-06-12 | $0.0067 | — | — |
| 2013-09-16 | 2013-10-17 | $0.0030 | — | — |
| 2013-05-16 | 2013-06-13 | $0.0052 | — | — |
| 2012-09-18 | 2012-10-18 | $0.0023 | — | — |
| 2012-05-18 | 2012-06-14 | $0.0039 | — | — |
| 2011-09-12 | 2011-10-13 | $0.0015 | — | — |
| 2011-05-04 | 2011-05-27 | $0.0026 | — | — |
| 2010-09-06 | 2010-09-29 | $0.0013 | — | — |
| 2010-04-23 | 2010-05-14 | $0.0021 | — | — |
| 2009-09-03 | 2009-09-24 | $0.0010 | — | — |
| 2009-04-27 | 2009-05-14 | $0.0014 | — | — |
| 2008-08-28 | 2008-09-18 | $0.0006 | — | — |
| 2008-04-23 | 2008-05-07 | $0.0010 | — | — |
About Lee's Pharmaceutical Holdings Limited (LPCUF) — Dividend Analysis 2026
Lee's Pharmaceutical Holdings Limited functions as an investment holding company primarily focused on the development, manufacturing, and commercialization of pharmaceutical products within the People's Republic of China. The company's therapeutic scope is broad, addressing various medical conditions across diverse areas such as cardiovascular health, women's health, pediatrics, rare diseases, oncology, dermatology, obstetrics, and urology. Its business operations are structured into two main segments: Proprietary and Generic Products, and Licensed-In Products. The Proprietary and Generic Products segment is responsible for producing and selling both its own internally developed medications and generic versions of established drugs. Notable products in this category include Livaracine, used to treat blood clots and deep vein thrombosis; Yallaferon for viral infections; Slounase, an agent for hemostasis; Eyprotor for corneal ulcers; Treprostinil injection for pulmonary arterial hypertension; fondaparinux sodium injection, also for deep vein thrombosis; and Sodium Phenylbutyrate Granules, which treat urea cycle disorders. Conversely, the Licensed-In Products segment manages the distribution and commercialization of pharmaceutical products obtained through licensing agreements with other companies. This extensive portfolio encompasses treatments such as Carnitene for carnitine deficiency; Aloxi and Sancuso for managing chemotherapy-induced nausea and vomiting; Bredinin, an immunosuppressant used in renal transplantation; Centraxal Plus for acute otitis media with tympanostomy tubes; Episil, which alleviates oral mucositis pain; Ferplex for iron deficiency anemia; and Gaslon N for gastric ulcers and gastritis. Additional offerings include Intrarosa for vulvovaginal atrophy; Levocarnitine oral solution for primary and secondary carnitine deficiency; Mictonorm for urinary incontinence; Natulan, indicated for Stage III and IV Hodgkin's disease; Omacor, containing Omega-3-acid ethyl esters; Zanidip and Rasilez for hypertension; Readyfusor for post-operative pain management; Teglutik for Amyotrophic lateral sclerosis; Trittico for insomnia and depression; Unidrox for urinary and respiratory tract infections; the probiotics Dicoflor and VSL#3; and Zingo, a topical local analgesic. Lee's Pharmaceutical was founded in 1994 and is headquartered in Sha Tin, Hong Kong.
Similar dividend stocks to LPCUF
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full LPCUF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open LPCUF position with:
🌍 LPCUF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold LPCUF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 3.00% | 0.20% | $300 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 2.55% | -0.25% | $255 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 2.40% | -0.40% | $240 / yr |
| 🇬🇧 UK ISA | 0% | 3.00% | 0.20% | $300 / yr |
| 🇬🇧 UK Taxable | 8.75% | 2.74% | -0.06% | $274 / yr |
| 🇨🇦 TFSA | 0% | 3.00% | 0.20% | $300 / yr |
| 🇨🇦 CA Taxable | 25% | 2.25% | -0.55% | $225 / yr |
| 🇦🇺 Super (pension) | 15% | 2.55% | -0.25% | $255 / yr |
| 🇦🇺 AU Taxable | 30% | 2.10% | -0.70% | $210 / yr |
| 🇩🇪 DE Taxable | 26.375% | 2.21% | -0.59% | $221 / yr |
| 🇫🇷 FR Taxable | 30% | 2.10% | -0.70% | $210 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 LPCUF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.01/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 LPCUF Dividend Payment Schedule
LPCUF pays quarterly — 4 times per year. Ex-div: 2026-09-29.
📊 LPCUF vs Healthcare Benchmarks
How LPCUF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for LPCUF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ LPCUF Insider Activity
No recent SEC filings reported in the last 90 days.Peer Group
Similar companies in the same sectorCompare LPCUF with peers: LPCUF vs ADOIF · LPCUF vs AMEUF · LPCUF vs CNVCF
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the LPCUF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Lee's Pharmaceutical Holdings Limited (LPCUF) is currently trading at $0.19, trading near its 52-week high. The current dividend yield is 3.00% based on an annual payout of $0.0057 per share.
LPCUF (Lee's Pharmaceutical Holdings Limited) — 3.00% Dividend Yield Analysis
Lee's Pharmaceutical Holdings Limited (LPCUF) is a healthcare stock currently trading at $0.19 with a dividend yield of 3.00%. It pays an annual dividend of $0.0057 per share. The payout ratio of 4% suggests the dividend is well-covered by earnings. Over the past 5 years, LPCUF's dividend has declined at an average rate of 6.3% a year.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest LPCUF News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.
How investors use the LPCUF dividend calculator
Illustrative examples of common use cases, written by the DividendFlow team — not customer reviews.